• Skip to main content

Diagnosis: Multiple Sclerosis

Coping with multiple sclerosis symptoms, attacks, and treatments

  • Home
  • About
  • Subscribe
  • What Is MS?
  • Gilenya
  • Contact Us

fingolimod

Are Neurologists Pushing Tysabri?

May 13, 2010 by Sara

Are Neurologists Pushing Tysabri?
Tysabri : A picture is worth $6900!

It was a dark and stormy night. The hospital corridors were abandoned and echoing with every step. There was a suspicious lack of signage directing individuals to the basement seminar. I had no idea that I had registered for an evening of neurologists pushing Tysabri onto a room full of medicare patients.

My parents assured me that although they’ve gone to many MS events they had never been to a spectacle like this before.

Last night I trekked down to the basement of a hospital branch one county away to attend an MS event my parents had alerted me to called Dialogue of Hope and Health. I can’t deny that I was hoping that the “hope” in the title of the event referred to the new oral medications soon to be available (at least in other countries) or perhaps stem cell developments. It turned out to be something between a sales pitch and damage control conducted by a local neurologist and some Tysabri sales reps.

[Read more…] about Are Neurologists Pushing Tysabri?

Filed Under: clabridine, copaxone, fingolimod, gilenya, insurance, liver damage, multiple sclerosis, rebif, research, treatment, tysabri Tagged With: cladribine, copaxone, disease, fingolimod, gilenya, injection, interferon, ms, ms attack, multiple sclerosis, natalizumab, neurological disorder, neurologist, pill, pml, rebif, tysabri

Oral Drugs For Multiple Sclerosis In 2011

January 21, 2010 by Sara

Oral Drugs For Multiple Sclerosis
Injections hurt!

Finally! Oral disease modifying drugs for Multiple Sclerosis are finally going to be available! I am so glad I make a habit of reading BBC News daily as US news agencies frequently skim over important things in favor of the shocking or violent. Today they published a story about new oral multiple sclerosis treatments that are likely to be available in England in 2011. As someone whose liver does not particularly like Interferon and is afraid of the risk of death from Tysabri infusions this might be a godsend. Since interferons are not available as generics (they contain living organisms and are exempt from status that would let them ever become generic) this could open inexpensive and more successful treatment options to a host of people who have no option but to live with the effects of the disease untreated. I am ecstatic that we finally have oral drugs for Multiple Sclerosis!

The full article and link to it are pasted below, but here is the basic information you want:

  • The oral drugs in question are Fingolimod and Cladribine
  • The drugs are considerably more effective at reducing relapses than current available treatments
  • The drugs may increase your chances of herpes and cancer

[Read more…] about Oral Drugs For Multiple Sclerosis In 2011

Filed Under: clabridine, fingolimod, gilenya, multiple sclerosis, rebif, treatment Tagged With: cladribine, disease, fingolimod, gilenya, interferon, ms, ms attack, multiple sclerosis, neurological disorder, pill, tysabri

Welcome!

January 1, 2010 by Sara

Welcome to DiagnosisMS.com!

I was diagnosed with Relapsing-Remitting Multiple Sclerosis December 10, 2008 and have since found myself on a mission to understand as much as humanly possible about the disease, its cause, its symptoms, and the mechanics of treatment for it. Some time ago I began to analyze Multiple Sclerosis and my personal experiences with the disease. My personal story will traverse multiple posts, but it is not an uncommon one for those of us with the disease.

[Read more…] about Welcome!

Filed Under: gilenya, insurance, multiple sclerosis, rebif, research, treatment Tagged With: fingolimod, gilenya, insurance, interferon, ms, multiple sclerosis, neurologist, rebif, solumedrol

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3

Copyright © 2022 · Infinity Pro on Genesis Framework · WordPress · Log in

 

Loading Comments...